Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Infectious Disease Working Party of the European Group for Bone Marrow Transplantation. 1994

P Ljungman, and P Biron, and A Bosi, and J Y Cahn, and A H Goldstone, and N C Gorin, and H Link, and C Messina, and M Michallet, and C Richard
Department of Medicine, Huddinge University Hospital, Sweden.

CMV pneumonia is rare following ABMT. No information has been presented concerning risk factors or outcome of antiviral therapy. Information concerning CMV pneumonia after ABMT was collected from bone marrow transplant centers in Europe. Twenty-one patients who fulfilled the diagnostic criteria of CMV pneumonia were reported. Eighteen of these patients were reported from centers who also reported the total number of ABMT performed. The CMV pneumonia frequency among 2252 reported ABMT patients was 0.8%, and this varied from 0% to 8.6% between different centers. Survival for > 30 days from diagnosis of pneumonia was 43%. Three patients suffered relapses, which were fatal, giving a total survival of 28%. Patients treated with or without TBI had a survival of 18% and 50%, respectively. Among patients given ganciclovir or foscarnet with or without intravenous immune globulin, survival at 30 days was 50% and total survival 28%. There was no difference in survival with or without the addition of intravenous immune globulin. CMV pneumonia is an infrequent but serious complication of ABMT.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D005060 Europe The continent north of AFRICA, west of ASIA and east of the ATLANTIC OCEAN. Northern Europe,Southern Europe,Western Europe
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

P Ljungman, and P Biron, and A Bosi, and J Y Cahn, and A H Goldstone, and N C Gorin, and H Link, and C Messina, and M Michallet, and C Richard
January 2001, Blood,
P Ljungman, and P Biron, and A Bosi, and J Y Cahn, and A H Goldstone, and N C Gorin, and H Link, and C Messina, and M Michallet, and C Richard
May 1996, Bone marrow transplantation,
P Ljungman, and P Biron, and A Bosi, and J Y Cahn, and A H Goldstone, and N C Gorin, and H Link, and C Messina, and M Michallet, and C Richard
January 1994, Annals of oncology : official journal of the European Society for Medical Oncology,
P Ljungman, and P Biron, and A Bosi, and J Y Cahn, and A H Goldstone, and N C Gorin, and H Link, and C Messina, and M Michallet, and C Richard
February 1998, Bone marrow transplantation,
P Ljungman, and P Biron, and A Bosi, and J Y Cahn, and A H Goldstone, and N C Gorin, and H Link, and C Messina, and M Michallet, and C Richard
December 1989, Bone marrow transplantation,
P Ljungman, and P Biron, and A Bosi, and J Y Cahn, and A H Goldstone, and N C Gorin, and H Link, and C Messina, and M Michallet, and C Richard
April 2001, Bone marrow transplantation,
P Ljungman, and P Biron, and A Bosi, and J Y Cahn, and A H Goldstone, and N C Gorin, and H Link, and C Messina, and M Michallet, and C Richard
June 2013, Transplant infectious disease : an official journal of the Transplantation Society,
P Ljungman, and P Biron, and A Bosi, and J Y Cahn, and A H Goldstone, and N C Gorin, and H Link, and C Messina, and M Michallet, and C Richard
June 1988, Lancet (London, England),
P Ljungman, and P Biron, and A Bosi, and J Y Cahn, and A H Goldstone, and N C Gorin, and H Link, and C Messina, and M Michallet, and C Richard
January 1991, Bone marrow transplantation,
P Ljungman, and P Biron, and A Bosi, and J Y Cahn, and A H Goldstone, and N C Gorin, and H Link, and C Messina, and M Michallet, and C Richard
March 1995, Bone marrow transplantation,
Copied contents to your clipboard!